SVI Annual Report

But more often than not it progresses slowly; with small, unsure steps, turning back and reinventing itself along the way. Our Deputy Director, Michael Parker, likens progress in medical research to a game of snakes and ladders. If things go well, you rapidly ascend a ladder that takes you closer to the answer, but more often than you would like you will find yourself circling back towards the beginning. More

Type 1 diabetes

Researchers from The University of Colorado (USA), in collaboration with St Vincent’s Institute of Medical Research (SVI) in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.More

Type 2 diabetes

Professor Bruce Kemp, Head of SVI’s Protein Chemistry and Metabolism Unit, has been awarded the prestigious 2016 Leach Medal at the 41st Lorne Conference on Protein Structure and Function. More

Bone disease

Bones are savvy. They are light, strong, and they can repair themselves when damaged. What’s more, they are continually renewing themselves, replacing old bone for new. More

Cancer

New research has shown that a specific protein in the cell called ADAR1 adds a distinct chemical signal to the cell’s own RNA –a ‘me’ signal—so that the cell can recognize the difference between its own RNA (self) and foreign RNA (non-self).More

Alzheimer's disease

Researchers from SVI have used the Australian Synchrotron to reveal important new detail of the structure of a drug currently in advanced clinical trials to combat Alzheimer’s disease.More

SVI's people

Although rarely lauded outside of the laboratory, research assistants and technicians are fundamental to medical research. They are multi-tasking, problem-solving, level-headed facilitators. More